Ravilóne M K, Esteves K, Koshi A, Rider G L, Stiblo K, Khomenko A G
Probl Tuberk. 1994(6):2-10.
According to WHO questionnaire data, reports of national ministries of health, medical associations and other medical institutions, tuberculosis morbidity in the majority of the East European countries and CIS surpasses that for the West Europe. In 1990-1992 it varied from 18 to 80 cases per 100,000 people. The lowest morbidity was recorded in the Czech Republic, the highest in Roumania and Kazakhstan. In Estonia, Latvia, Lithuania, Russia and Ukraine tuberculosis morbidity tends to a slow reduction, while in Armenia, Kyrgyzstan, Latvia, Lithuania, Moldova, Roumania, Turkmenistan mortality rates constantly grow. Antituberculous therapeutic and prophylactic policy in the East Europe and CIS should be aimed at finding the resources for adequate supply of the population with antituberculous medications, introduction of WHO-recommended short course of chemotherapy. On demand, health care system should be restructured and new educational programs for specialists and the population introduced.
根据世界卫生组织的问卷调查数据、各国卫生部报告、医学协会及其他医疗机构的数据,多数东欧国家和独联体国家的结核病发病率超过西欧国家。1990 - 1992年期间,发病率为每10万人中有18至80例。发病率最低的是捷克共和国,最高的是罗马尼亚和哈萨克斯坦。在爱沙尼亚、拉脱维亚、立陶宛、俄罗斯和乌克兰,结核病发病率呈缓慢下降趋势,而在亚美尼亚、吉尔吉斯斯坦、拉脱维亚、立陶宛、摩尔多瓦、罗马尼亚、土库曼斯坦,死亡率持续上升。东欧和独联体的抗结核治疗和预防政策应致力于寻找资源,以确保民众能够获得充足的抗结核药物供应,并采用世界卫生组织推荐的短程化疗方案。根据需求,应重组医疗保健系统,并为专业人员和民众推出新的教育项目。